The North America Lab Automation Market is expanding as pharmaceutical and biotechnology companies, clinical laboratories, academic research institutions, and healthcare organizations increasingly adopt automated technologies to improve laboratory efficiency, accuracy, throughput, and reproducibility. The region benefits from a strong life sciences ecosystem, substantial research and development activities, advanced healthcare infrastructure, and growing demand for automated workflows across drug discovery, genomics, diagnostics, and clinical research.

The Lab Automation Market size is expected to reach US$ 8.71 billion by 2031 from US$ 5.76 billion in 2024. The market is anticipated to register a CAGR of 6.3% during 2025–2031.

What is driving the market?

Rising sample volumes, strict data integrity regulations, and the need for standardized, error-free testing serve as the primary growth drivers. Laboratories are increasingly adopting automated systems to manage complex assays in drug discovery, genomics, and clinical diagnostics. Modern diagnostic platforms require precise liquid handling, high-throughput screening, and continuous sample tracking—tasks where manual processing introduces costly delays and variability.

The market is moving beyond standalone benchtop automated instruments toward end-to-end connected ecosystems. Equipment providers and software developers are integrating automated workstations with cloud-based Laboratory Information Management Systems (LIMS), machine learning analytics, and real-time process tracking. High initial capital investments, complex integration with legacy infrastructure, and the need for specialized technical training remain notable market constraints.

Which region leads?

North America leads the market, accounting for an estimated 36%–39% share in 2025. Its dominant position is supported by substantial biopharmaceutical R&D expenditure, early adoption of robotics and AI, advanced healthcare infrastructure, and strong presence of major market players.

Asia Pacific is the fastest-growing regional market, projected to expand at the highest CAGR during the forecast period. Growth in Asia Pacific is fueled by expanding pharmaceutical manufacturing capacity, investments in life sciences infrastructure, rising clinical diagnostic testing volumes, and government initiatives across China, India, Japan, and South Korea. Europe holds a significant share (estimated 26%–29%), driven by a well-established biotechnology industry and strict regulatory requirements regarding diagnostic accuracy and data traceability.

Which segment leads?

By Equipment & Component Type, Automated Liquid Handling Systems holds the leading position, accounting for nearly 38% of equipment revenue. Its dominance is driven by its essential role in sample preparation, reagent dispensing, serial dilution, and high-throughput screening assays. By automation architecture, Modular Automation holds the largest revenue share (~57.6%) due to its flexibility and lower upfront deployment cost compared to full total lab automation (TLA) systems.

By End-Use Application, Clinical Diagnostics represents the leading and fastest-growing application segment. This is supported by surging volumes of patient samples, routine blood panels, immunoassay screenings, and molecular diagnostic testing. Drug Discovery & Life Science Research forms another major end-use market, driven by high-throughput screening and target validation applications.

Which companies are prominent?

The report identifies Thermo Fisher Scientific Inc., Danaher Corporation, Tecan Group Ltd., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, PerkinElmer Inc., Hamilton Company, QIAGEN N.V., and Waters Corporation as prominent market participants.

These companies compete across liquid handling, robotic sample transport, automated storage, microplate readers, and informatics software. Strategic differentiation relies on software interoperability, modular scalability, assay flexibility, cloud connectivity, and seamless integration with diagnostic reagent kits. This list reflects the report's competitive landscape rather than a revenue-ranked market-share table.

What is changing in 2026?

The market is rapidly shifting from isolated equipment upgrades to modular, AI-orchestrated lab automation platforms. Laboratories demand plug-and-play interoperability, allowing instruments from different vendors to communicate using standardized communication protocols (such as SiLA and OPC UA). Additionally, data security, audit trail compliance, and automated quality control have become central to capital purchasing decisions.

Vendors are accelerating the development of compact benchtop systems designed for mid-sized and regional diagnostic labs that lack the footprint or budget for full floor-standing tracks. Dynamic scheduling software, predictive maintenance algorithms, and remote workflow monitoring are transitioning from premium add-ons to essential baseline requirements across clinical and industrial laboratories.

What are the major investment opportunities?

The strongest investment opportunities lie in AI-powered scheduling and workflow software, compact modular liquid handlers, automated sample management/cryo-storage, and multi-vendor middleware solutions. Solutions that enable mid-tier and smaller laboratories to automate routine sample preparation without complete facility overhauls represent significant untapped growth potential.

Additional high-growth opportunities exist in biobanking automation, high-content screening technologies, cellular analysis systems, and automated point-of-care sample preparation platforms. Expanding clinical diagnostic networks across Asia Pacific, Latin America, and the Middle East offers attractive expansion routes for equipment manufacturers that provide flexible deployment options, reliable technical support, and competitive total cost of ownership.

About The Insight Partners

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Information

•              Email: sales@theinsightpartners.com

•              Website: theinsightpartners.com

•              Phone: +1-646-491-9876